Skip to main content

Table 4 Factors associated with multi-drug resistant tuberculosis

From: Epidemiology of anti-tuberculosis drug resistance in a chinese population: current situation and challenges ahead

Factors Cases No-MDR MDR cOR(95% CI) P aOR(95% CI) * P
  n = 1824 n = 1521, n(%) n = 303, n(%)     
Sex        
   Men 1340 1129(84.25) 211(15.75) 1   1  
   Women 484 392(80.99) 92(19.01) 1.26(0.96-1.65) 0.099 1.43(0.99-2.06) 0.058
Age (years)        
   65+ 547 465(85.01) 82(14.99) 1   1  
   55-64 298 247(82.89) 51(17.11) 1.17(0.80-1.72) 0.418 1.11(0.74-1.67) 0.602
   45-54 276 217(78.62) 59(21.38) 1.54(1.06-2.24) 0.022 1.53(1.03-2.28) 0.035
   35-44 270 208(77.04) 62(22.96) 1.69(1.17-2.44) 0.005 1.88(1.26-2.81) 0.002
   25-34 188 169(89.89) 19(10.11) 0.64(0.38-1.08) 0.095 0.87(0.49-1.53) 0.626
   < 25 245 215(87.76) 30(12.24) 0.79(0.51-1.24) 0.306 1.38(0.84-2.29) 0.206
Treatment history #        
   No 1180 1090(92.37) 90(7.63) 1   1  
   Yes 644 431(66.93) 213(33.07) 5.99(4.57-7.84) < 0.001 6.14(4.61-8.17) < 0.001
Area of residence        
   South 718 623(86.77) 95(13.23) 1   1  
   Central 343 280(81.63) 63(18.37) 1.48(1.04-2.09) 0.029 1.47(1.01-2.13) 0.044
   North 763 618(81.00) 145(19.00) 1.54(1.16-2.04) 0.003 1.42(1.05-1.92) 0.023
Cigarette smoking &        
   Never 862 706(81.90) 156(18.10) 1   1  
   Ever 954 809(84.80) 145(15.20) 0.81(0.63-1.04) 0.098 1.01(0.72-1.42) 0.942
  1. †:MDR, multidrug-resistant, resistance to at least isoniazid and rifampicin; ‡: cOR, crude odds ratio; *aOR, adjusted odds ratio, adjusted for sex, age, treatment history, area and cigarette smoking; #:Those having previously received anti-tuberculosis treatment for more than one month was defined as previously treated cases; &: 8 cases with missing value.